{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:08:34Z","timestamp":1782846514628,"version":"3.54.5"},"reference-count":59,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Spinal muscular atrophy (SMA) is a rare neuromuscular disease and the most common genetic cause of infant death. Although pharmacological treatment improves survival rates and functional capacity, physiotherapy remains a key component of care. A newly developed innovative equine-assisted physiotherapy method based on neuroproprioceptive \u201cfacilitation and inhibition\u201d principles (NEUROEQUIP-SMA) is hypothesized to improve the quality and extent of motor development in children with SMA.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The aim of this study is to assess the efficacy of NEUROEQUIP-SMA compared with standard individual outpatient physiotherapy based on the same neuroproprioceptive \u201cfacilitation and inhibition\u201d principles (SMA-SOC-N) and to evaluate its effects on functional outcomes and quality of life (QoL). In addition, the response of molecular biomarkers to treatment will be assessed.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this crossover randomized controlled trial, 20 children with SMA types I-III, aged 2\u20109 years, will participate in two 6-day therapy programs (A and B) of equal duration (50 min per day) and separated by a 10-week washout period. Each child will be randomly assigned to receive the therapies in either the AB or BA sequence. Therapy A consists of a newly developed NEUROEQUIP-SMA (15 min twice daily), whereas therapy B involves SMA-SOC-N (30 min once daily). Both programs include therapeutic horse grooming (20 min a day). The Children\u2019s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) was selected as the primary outcome measure. Secondary outcomes included motor coordination assessed through 3D motion analysis, muscle fatigue, spirometry, and standardized clinical tests and rating scales, as well as monitoring of psychomotor development (via home-video analysis) and QoL (via questionnaires). Molecular biomarkers will be analyzed from blood samples. The immediate effect of the intervention will be evaluated for most outcomes, while psychomotor development and QoL will be monitored 28 days after therapy as longer-term outcomes. Treatment effect sizes will be reported alongside\n P<\/jats:italic>\n values to illustrate the magnitude of changes in the outcomes. The study was approved by the Ethics Committee of the Third Faculty of Medicine, Charles University, under the number UK3LF\/658559\/12025.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The study is designed for 20 participants. Data collection will begin in February 2026 and will be completed in May 2026. Data analyses are planned for autumn 2026, and study results are expected to be available in 2027. A paired\n t<\/jats:italic>\n test comparing the primary outcome (CHOP INTEND) between treatments NEUROEQUIP-SMA and SMA-SOC-N in 20 children will have 80% power to detect moderate-to-large effect size (Cohen\n d<\/jats:italic>\n =0.66) at a 5% significance level.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This trial will be the first study to evaluate the effects of NEUROEQUIP-SMA in children with SMA. If preliminary findings confirm a benefit, this physiotherapy approach may represent a promising adjunct to care for the generation of children undergoing gene therapy.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/83266","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:30:05Z","timestamp":1765362605000},"page":"e83266-e83266","source":"Crossref","is-referenced-by-count":0,"title":["Immediate and Sustained Effects of Intensive Equine-Assisted Physiotherapy Based on Neuroproprioceptive \u201cFacilitation and Inhibition\u201d on Psychomotor Development, Clinical Functions, Quality of Life, and Molecular Biological Indicators in Children With Spinal Muscular Atrophy: Protocol for a Crossover Randomized Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7583-156X","authenticated-orcid":false,"given":"Katerina","family":"Marikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5402-699X","authenticated-orcid":false,"given":"Jindra","family":"Reissigova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1449-8869","authenticated-orcid":false,"given":"Miloslav","family":"Vilimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-5588","authenticated-orcid":false,"given":"Marie","family":"Cerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5789-8413","authenticated-orcid":false,"given":"Marketa","family":"Pokorna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3201-1770","authenticated-orcid":false,"given":"Kamila","family":"Rasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"4","key":"R1","doi-asserted-by":"publisher","DOI":"10.3390\/children11040495","article-title":"Considerations for treatment in clinical care of spinal muscular atrophy patients","volume":"11","author":"Voight","journal-title":"Children (Basel)"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.36713\/epra12994","article-title":"Spinal muscular atrophy clinical features, classification, natural history, genetics, diagnosis, complications and treatment of the disease","author":"Garc\u00eda","journal-title":"EPRA"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","journal-title":"Muscle Nerve"},{"issue":"5","key":"R4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","article-title":"Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients","volume":"27","author":"Rouault","journal-title":"Neuromuscul Disord"},{"issue":"15","key":"R5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511939","article-title":"Spinal muscular atrophy: the past, present, and future of diagnosis and treatment","volume":"24","author":"Nishio","journal-title":"Int J Mol Sci"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","journal-title":"Nat Rev Dis Primers"},{"issue":"1-2","key":"R7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.31128\/AJGP-03-21-5924","article-title":"The changing therapeutic landscape of spinal muscular atrophy","volume":"51","author":"Davidson","journal-title":"Aust J Gen Pract"},{"issue":"3","key":"R8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/ijph.IJPH_239_18","article-title":"Exploring spinal muscular atrophy and its impact on functional status: Indian scenario","volume":"63","author":"Bose","journal-title":"Indian J Public Health"},{"issue":"5","key":"R9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/088307389701200507","article-title":"Muscle fatigue in spinal muscular atrophy","volume":"12","author":"Iannaccone","journal-title":"J Child Neurol"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mus.24568","article-title":"Resistance strength training exercise in children with spinal muscular atrophy","volume":"52","author":"Lewelt","journal-title":"Muscle Nerve"},{"issue":"2","key":"R11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5734\/JGM.2020.17.2.55","article-title":"Rehabilitation of spinal muscular atrophy: current consensus and future direction","volume":"17","author":"Yi","journal-title":"J Genet Med"},{"issue":"2","key":"R12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/PRM-160360","article-title":"Physical therapy services received by individuals with spinal muscular atrophy (SMA)","volume":"9","author":"Dunaway","journal-title":"J Pediatr Rehabil Med"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5603\/PJNNS.a2019.0068","article-title":"Spinal muscular atrophy - new therapies, new challenges","volume":"54","author":"J\u0119drzejowska","journal-title":"Neurol Neurochir Pol"},{"issue":"7","key":"R15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1113\/JP271361","article-title":"Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice","volume":"594","author":"Chali","journal-title":"J Physiol"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.954712","article-title":"COMIRESTROKE-a clinical study protocol for monitoring clinical effect and molecular biological readouts of prehensive ntensive habilitation program after : a four-arm parallel-group randomized double blinded controlled trial with a longitudinal design","volume":"13","author":"\u0158asov\u00e1","journal-title":"Front Neurol"},{"issue":"6","key":"R17","doi-asserted-by":"publisher","DOI":"10.23736\/S1973-9087.21.06701-0","article-title":"A Three-Arm Parallel-group Exploratory Trial documents balance improvement without much evidence of white matter integrity changes in people with multiple sclerosis following two months ambulatory neuroproprioceptive \u201cfacilitation and inhibition\u201d physical therapy","volume":"57","author":"\u0158asov\u00e1","journal-title":"Eur J Phys Rehabil Med"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01715-9","article-title":"Effects of hippotherapy on motor function of children with cerebral palsy: a systematic review study","volume":"50","author":"Plotas","journal-title":"Ital J Pediatr"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/acm.2020.0415","article-title":"Optimal terminology for services in the United States that incorporate horses to benefit people: a consensus document","volume":"27","author":"Wood","journal-title":"J Altern Complement Med"},{"issue":"4","key":"R20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/ajpy.12246","article-title":"An umbrella review of the evidence for equine\u2010assisted interventions","volume":"71","author":"Stern","journal-title":"Aust J Psychol"},{"issue":"9","key":"R21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/jicm.2021.0417","article-title":"Does hippotherapy improve the functions in children with cerebral palsy? Systematic review based on the international classification of functioning","volume":"28","author":"Pantera","journal-title":"J Integr Complement Med"},{"issue":"2","key":"R22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/PEP.0000000000000880","article-title":"The short-term effects of hippotherapy and therapeutic horseback riding on spasticity in children with cerebral palsy: a meta-analysis","volume":"34","author":"Hyun","journal-title":"Pediatr Phys Ther"},{"issue":"2","key":"R23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/PEP.0000000000000027","article-title":"Perceptions of equine-assisted activities and therapies by parents and children with spinal muscular atrophy","volume":"26","author":"Lemke","journal-title":"Pediatr Phys Ther"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2016.11.033","article-title":"The antisense transcript SMN-AS1 regulates SMN expression and is a novel therapeutic target for spinal muscular atrophy","volume":"93","author":"d\u2019Ydewalle","journal-title":"Neuron"},{"issue":"5","key":"R25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12050932","article-title":"lncRNA biomarkers of glioblastoma multiforme","volume":"12","author":"Pokorn\u00e1","journal-title":"Biomedicines"},{"issue":"3","key":"R26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.celrep.2015.03.043","article-title":"PARTICLE, a triplex-forming long ncRNA, regulates locus-specific methylation in response to low-dose irradiation","volume":"11","author":"O\u2019Leary","journal-title":"Cell Rep"},{"issue":"6","key":"R27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/jnc.15198","article-title":"Long non-coding RNAs in motor neuron development and disease","volume":"156","author":"Vangoor","journal-title":"J Neurochem"},{"key":"R28","unstructured":"pwr: basic functions for power analysis. R Project. URL: http:\/\/cran.r-project.org\/web\/packages\/pwr\/index.html [Accessed 06-01-2026]"},{"key":"R29","unstructured":"Create a blocked randomisation list. Sealed envelope. URL: https:\/\/www.sealedenvelope.com\/simple-randomiser\/v1\/lists [Accessed 15-05-2025]"},{"key":"R30","unstructured":"Ministry of Health of the Czech Republic. Decision on the extension of accreditation nomzdr 39110\/2019-7\/ONP [internal document provided to the authors\u2019 institution]. Ministry of Health; 2019."},{"key":"R31","unstructured":"Ministry of Health of the Czech Republic. Decision on the granting of accreditation no.55296\/2014-3\/ONP [internal document provided to the authors\u2019 institution]. Ministry of Health; 2014."},{"issue":"6","key":"R32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.23736\/S1973-9087.21.06701-0","article-title":"A three-arm parallel-group exploratory trial documents balance improvement without much evidence of white matter integrity changes in people with multiple sclerosis following two months ambulatory neuroproprioceptive \u201cfacilitation and inhibition\u201d physical therapy","volume":"57","author":"\u0158asov\u00e1","journal-title":"Eur J Phys Rehabil Med"},{"issue":"4","key":"R33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nmd.2014.01.003","article-title":"Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients","volume":"24","author":"Mazzone","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"R34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The Children\u2019s Hospital of Philadelphia infant test of neuromuscular disorders (CHOP INTEND): test development and reliability","volume":"20","author":"Glanzman","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"R35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1469-8749.2008.03186.x","article-title":"Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy","volume":"51","author":"Fowler","journal-title":"Dev Med Child Neurol"},{"issue":"20","key":"R36","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.5897\/SRE10.1185","article-title":"Reliability of balance tests in children with duchenne muscular dystrophy","volume":"6","author":"Bahar","journal-title":"Sci Res Essays"},{"issue":"2","key":"R37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.PEP.0000067885.63909.5C","article-title":"Validity and reliability of a pediatric reach test","volume":"15","author":"Bartlett","journal-title":"Pediatr Phys Ther"},{"issue":"2","key":"R38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","journal-title":"Eur Respir J"},{"issue":"6","key":"R39","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","journal-title":"Eur Respir J"},{"issue":"18","key":"R40","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16183426","article-title":"The angle of trunk rotation in school children: a study from an idiopathic scoliosis screening. prevalence and optimal age screening value","volume":"16","author":"Adamczewska","journal-title":"Int J Environ Res Public Health"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Sakanaka TE Butler P Kulshrestha R Willis T Loram I . Children with spinal muscular atrophy treated with disease-modifying therapies, do they attain neutral vertical head and trunk control? Rehabilitation Medicine and Physical Therapy. [doi: 10.1101\/2025.02.24.25321598]","DOI":"10.1101\/2025.02.24.25321598"},{"issue":"3","key":"R42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/PEP.0b013e3181e69490","article-title":"Refinement, reliability, and validity of the segmental assessment of trunk control","volume":"22","author":"Butler","journal-title":"Pediatr Phys Ther"},{"issue":"6","key":"R43","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1177\/00315125241286622","article-title":"Reliability and validity of the Trunk Control Measurement Scale in children with duchenne muscular dystrophy","volume":"131","author":"Bulut","journal-title":"Percept Mot Skills"},{"issue":"6","key":"R44","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.ridd.2011.06.012","article-title":"A clinical tool to measure trunk control in children with cerebral palsy: the Trunk Control Measurement Scale","volume":"32","author":"Heyrman","journal-title":"Res Dev Disabil"},{"key":"R45","unstructured":"Comprehensive ICF core set for children and youth with CP. ICF Research Branch. URL: https:\/\/www.icf-research-branch.org\/icf-core-sets?task=download.send&id=210:comprehensive-icf-core-set-for-children-and-youth-with-cp&catid=20 [Accessed 27-03-2025]"},{"issue":"8","key":"R46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","journal-title":"Med Care"},{"issue":"5","key":"R47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","article-title":"The Strengths and Difficulties Questionnaire: a research note","volume":"38","author":"Goodman","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"R48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96567-2","article-title":"Optimized protocol for the extraction of RNA and DNA from frozen whole blood sample stored in a single EDTA tube","volume":"11","author":"Yamagata","journal-title":"Sci Rep"},{"key":"R49","unstructured":"The R Project for Statistical Computing. URL: https:\/\/www.R-project.org\/ [Accessed 24-12-2025]"},{"key":"R50","unstructured":"Community update on access to Spinraza in Europe. SMA Europe. URL: https:\/\/www.sma-europe.eu\/news\/community-update-on-access-to-spinraza-in-europe [Accessed 04-08-2025]"},{"key":"R51","unstructured":"Czech Republic allows pre-authorized use of Zolgensma. Eversana. URL: https:\/\/www.eversana.com\/2020\/04\/23\/czech-republic-preauthorized-zolgensma [Accessed 04-08-2025]"},{"issue":"3","key":"R52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/ijabmr.IJABMR_190_19","article-title":"Onasemnogene abeparvovec for spinal muscular atrophy: the costlier drug ever","volume":"9","author":"Mahajan","journal-title":"Int J Appl Basic Med Res"},{"key":"R53","unstructured":"Zolgensma data, including patients with more severe SMA at baseline, further demonstrate therapeutic benefit, including prolonged event-free survival, increased motor function, and milestone achievement. NOVARTIS. URL: https:\/\/www.novartis.com\/news\/media-releases\/zolgensma-data-including-patients-more-severe-sma-baseline-further-demonstrate-therapeutic-benefit-including-prolonged-event-free-survival-increased-motor-function-and-milestone-achievement [Accessed 04-08-2025]"},{"issue":"5","key":"R54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nmd.2021.02.011","article-title":"Filling the gaps in knowledge translation: physical therapy recommendations for individuals with spinal muscular atrophy compared to standard of care guidelines","volume":"31","author":"Trenkle","journal-title":"Neuromuscul Disord"},{"issue":"21","key":"R55","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1080\/09638288.2025.2484345","article-title":"Rehabilitation practices for childhood spinal muscular atrophy","volume":"47","author":"Mortenson","journal-title":"Disabil Rehabil"},{"issue":"1","key":"R56","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-021-00162-9","article-title":"Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders","volume":"4","author":"Jablonka","journal-title":"Neurol Res Pract"},{"issue":"1","key":"R57","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03888-w","article-title":"Rehabilitation management for patients with spinal muscular atrophy: a review","volume":"20","author":"Song","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"R58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5535\/arm.240046","article-title":"Rehabilitation strategies for patients with spinal muscular atrophy in the era of disease-modifying therapy","volume":"48","author":"Shin","journal-title":"Ann Rehabil Med"},{"issue":"8","key":"R59","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.3390\/app15084398","article-title":"Physical and respiratory rehabilitation in spinal muscular atrophy: a critical narrative review","volume":"15","author":"Cammarano","journal-title":"Appl Sci (Basel)"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e83266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:17:21Z","timestamp":1782843441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e83266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":59,"URL":"https:\/\/doi.org\/10.2196\/83266","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"v15i4e83266"}}